In recent years, a peptide called BPC-157 has emerged as a potential game-changer in this endeavour
This collaboration builds on the successfully progressing joint research projects between the companies, aiming to identify, validate, and develop innovative treatments to improve health outcomes for individuals living with obesity
But many of these products carry an additional legal defect that goes beyond advertising claims: they are not lawful products to begin with
Symptoms include nausea, diarrhea, vomiting and constipation, occurring twice as often as patients treated with placebo
In the early 2000s, a surge of companies began exploring the potential of constrained peptides, motivated by the belief that these molecules could target previously inaccessible intracellular sites
Key points include: use an alcohol swab on the vial stopper before each draw, inject bacteriostatic water slowly down the side of the vial (never directly onto the powder), and gently swirl rather than shake to dissolve